PROTECT (Stem Cell Transplantation)

What is the Purpose of this Study?

If you choose to join this study, you will:
- Fill out questionnaires about your mood, quality of life, and symptoms
- Be randomly assigned (like a coin flip) to 1 of 2 groups
-- One group will receive standard transplant oncology care
-- The other group will receive standard transplant oncology care with early palliative care
What is the Condition Being Studied?
Blood Cancers

Who Can Participate in this Study?

Adults ages 18+ who:

- Are diagnosed with a blood cancer

- Will be hospitalized to receive a stem cell transplant

- Can read and speak English or Spanish

For more information about who can join this study, please contact the study team at sarah.lacinski@duke.edu.

Age Group
Adults
Participating Institutions

What is Involved?

We are doing this study to find out if it is better to introduce patients undergoing stem cell transplantation to their palliative care team early. This team specializes in symptoms management and can improve the physical and psychological symptoms that patients and their families experience during hospitalization for stem cell transplantation.

Study Details

Full Title
Multi-Site Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
Principal Investigator

Contacts
Protocol Number
IRB:
PRO00100908

NCT:
NCT03641378
ClinicalTrials.gov
View on ClinicalTrials.gov